Sutro Biopharma (STRO) Long-Term Investments (2019 - 2022)
Sutro Biopharma (STRO) posted Long-Term Investments of $20.7 million for Q1 2022, down 69.91% sequentially from $68.8 million in Q4 2021, and down 72.25% YoY from $74.6 million in Q1 2021.
Sutro Biopharma (STRO) Long-Term Investments (2019 - 2022) Analysis & Trends
Sutro Biopharma has reported Long-Term Investments for 4 years, with the latest figure at $20.7 million in Q1 2022.
- Quarterly Long-Term Investments fell 72.25% year-over-year to $20.7 million in Q1 2022, while the trailing twelve-month figure through Mar 2022 was $20.7 million (down 72.25% YoY) and the FY2021 annual result came in at $68.8 million, changed N/A from the prior year.
- Long-Term Investments eased to $20.7 million in Q1 2022 per STRO's latest filing, from $68.8 million in the prior quarter.
- Over five years, Long-Term Investments peaked at $74.6 million in Q1 2021 and troughed at $5.6 million in Q2 2020.
- A 4-year average of $34.3 million and a median of $20.7 million in 2022 frame the typical range for Long-Term Investments.
- The sharpest annual moves came in 2021 and 2022: Long-Term Investments surged 962.51% in 2021, then tumbled 72.25% in 2022.
- Over 4 years, Long-Term Investments stood at $15.6 million in 2019, then plunged by 63.8% to $5.6 million in 2020, then jumped by 1118.35% to $68.8 million in 2021, then slumped by 69.91% to $20.7 million in 2022.
- According to Business Quant data, Long-Term Investments over the past three periods registered $20.7 million, $68.8 million, and $64.3 million for Q1 2022, Q4 2021, and Q3 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 5.79 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 9.83 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 372.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 22.17 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Sutro Biopharma | 339.58 Mn | 175.24 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 20.70 Mn |
| Dec 31, 2021 | 68.80 Mn |
| Sep 30, 2021 | 64.28 Mn |
| Jun 30, 2021 | 60.00 Mn |
| Mar 31, 2021 | 74.60 Mn |
| Jun 30, 2020 | 5.65 Mn |
| Mar 31, 2020 | 14.19 Mn |
| Dec 31, 2019 | 15.60 Mn |
| Sep 30, 2019 | 25.22 Mn |
| Jun 30, 2019 | 15.06 Mn |
| Mar 31, 2019 | 13.75 Mn |